[Local and systemic antimycotic therapy of Candida-induced denture stomatitis].
15 patients with clinically outstanding prosthesis stomatitis due to microscopically proved candida infection underwent treatment with the antimycotic agent Clotrimazol. After two weeks' therapy improvement was observed in 6 patients (40%), healing in 4 patients (27%); 4 patients did not respond and in one patient the condition was temporally made worse. Examination two weeks after cessation of therapy showed that the clinical condition in 8 patients was as bad as before therapy (53%), and 4 patients (27%) were symptom-free. 3 patients (20%) had improved further. Suggestions for the treatment of prosthesis stomatitis can be derived from these findings.
D001431:Bacteriological Techniques; D002176:Candida albicans / Q000302:isolation & purification*; D002180:Candidiasis, Oral / Q000188:drug therapy* / Q000209:etiology; D003022:Clotrimazole / Q000627:therapeutic use*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D013280:Stomatitis / Q000188:drug therapy*; D013282:Stomatitis, Denture / Q000188:drug therapy* / Q000382:microbiology
D007093:Imidazoles; D003022:Clotrimazole
Lokale und systemische antimykotische Therapie der Candida-Prothesenstomatitis.